NCT04649580View on ClinicalTrials.gov

United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

June 5, 2022

Study Completion Date

June 5, 2022

Conditions
Neuroendocrine Tumours (NET)
Trial Locations (5)

B15 2GW

University Hospitals Birmingham NHS Foundation Trust, Birmingham

CF14 4HH

Cardiff and Vale University LHB, Cardiff

CV2 2DX

University Hospitals Coventry and Warwickshire NHS Trust, Coventry

L7 8XP

Liverpool University Hospitals NHS Foundation Trust, Liverpool

NW3 2QG

Royal Free London NHS Foundation Trust, London

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY